GodseKSarkarRMysoreV, et alOral tranexamic acid for the treatment of melasma: evidence and experience-based consensus statement from Indian experts. Indian J Dermatol. 2023;68(2):178-185. doi:10.4103/ijd.ijd_266_22
2.
KucekiGMendezDGarza-DueñasGGKruithoffCFonsecaLOLalK.No thromboembolic events observed in RCTs of oral tranexamic acid: a systematic review and descriptive synthesis. J Am Acad Dermatol. 2025;93(4):1086-1088. doi:10.1016/j.jaad.2025.06.001
3.
LeeHCThngTGGohCL.Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385-392. doi:10.1016/j.jaad.2016.03.001
4.
MeaidiAMørchLTorp-PedersenCLidegaardO.Oral tranexamic acid and thrombosis risk in women. EClinicalMedicine. 2021;35:100882. doi:10.1016/j.eclinm.2021.100882
5.
LamKMansourDSuttonA.Oral tranexamic acid treatment beyond 6 months for melasma patients—a retrospective case series. JAAD Int. 2024;15:195-196. doi:10.1016/j.jdin.2024.03.006
